CS
Cannell & Spears Portfolio holdings
AUM
$4.95B
This Quarter Return
+5.27%
1 Year Return
+21.47%
3 Year Return
+82.49%
5 Year Return
+137.04%
10 Year Return
+287.57%
AUM
$805M
AUM Growth
+$805M
(+1.7%)
Cap. Flow
-$13.2M
Cap. Flow
% of AUM
-1.64%
Top 10 Holdings %
Top 10 Hldgs %
44.94%
Holding
152
New
20
Increased
17
Reduced
38
Closed
7
Top Buys
| 1 |
Ball Corp
BALL
|
$10.7M |
| 2 |
Vanguard Small-Cap Value ETF
VBR
|
$1.7M |
| 3 |
GE Aerospace
GE
|
$646K |
| 4 |
Bristol-Myers Squibb
BMY
|
$590K |
| 5 |
CSX Corp
CSX
|
$558K |
Top Sells
| 1 |
KeyCorp
KEY
|
$3.18M |
| 2 |
Apple
AAPL
|
$2.17M |
| 3 |
Comcast
CMCSA
|
$2.03M |
| 4 |
Thermo Fisher Scientific
TMO
|
$2.02M |
| 5 |
American International
AIG
|
$1.68M |
Sector Composition
| 1 | Financials | 25.5% |
| 2 | Healthcare | 18.94% |
| 3 | Technology | 16.09% |
| 4 | Industrials | 13.05% |
| 5 | Consumer Discretionary | 10.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Fortive
FTV
$16.2B
| $9.91M | 1.23% |
156,500
-155
| -0.1% | -$9.82K |
|
27
Johnson & Johnson
JNJ
$427B
| $6.8M | 0.85% |
51,399
+405
| +0.8% | +$53.6K |
|
28
AXIS Capital
AXS
$7.71B
| $4.75M | 0.59% |
73,523
| – | – |
|
29
UnitedHealth
UNH
$281B
| $4.22M | 0.52% |
22,763
-863
| -4% | -$160K |
|
30
SPDR S&P 500 ETF Trust
SPY
$658B
| $3.51M | 0.44% |
14,526
+150
| +1% | +$36.3K |
|
31
Union Bankshares
UNB
$119M
| $2.82M | 0.35% |
59,357
-1,675
| -3% | -$79.6K |
|
32
Exxon Mobil
XOM
$487B
| $2.76M | 0.34% |
34,134
-2,271
| -6% | -$183K |
|
33
Aon
AON
$79.1B
| $2.66M | 0.33% |
20,041
+1,500
| +8% | +$199K |
|
34
Berkshire Hathaway Class B
BRK.B
$1.09T
| $2.39M | 0.3% |
14,124
+1,200
| +9% | +$203K |
|
35
Biogen
BIIB
$19.4B
| $1.93M | 0.24% |
7,115
| – | – |
|
36
Trimble
TRMB
$19.2B
| $1.86M | 0.23% |
52,000
| – | – |
|
37
Wells Fargo
WFC
$263B
| $1.81M | 0.22% |
32,635
-30
| -0.1% | -$1.66K |
|
38
Procter & Gamble
PG
$368B
| $1.77M | 0.22% |
20,248
| – | – |
|
|
39
Vanguard Small-Cap Value ETF
VBR
$31.4B
| $1.7M | 0.21% |
+13,820
| New | +$1.7M |
|
40
Merck
MRK
$210B
| $1.67M | 0.21% |
26,086
| – | – |
|
41
Adient
ADNT
$2.01B
| $1.66M | 0.21% |
25,311
-2,302
| -8% | -$151K |
|
42
Kinder Morgan
KMI
$60B
| $1.65M | 0.2% |
85,932
| – | – |
|
43
iShares Biotechnology ETF
IBB
$5.6B
| $1.57M | 0.19% |
5,058
| – | – |
|
44
Starbucks
SBUX
$100B
| $1.29M | 0.16% |
22,049
| – | – |
|
|
45
Berkshire Hathaway Class A
BRK.A
$1.09T
| $1.27M | 0.16% |
5
| – | – |
|
46
iShares Russell 1000 Growth ETF
IWF
$116B
| $1.27M | 0.16% |
10,640
| – | – |
|
47
3M
MMM
$82.8B
| $1.21M | 0.15% |
5,824
-121
| -2% | -$25.2K |
|
48
Crown Castle
CCI
$43.2B
| $1.18M | 0.15% |
11,725
| – | – |
|
49
Aramark
ARMK
$10.3B
| $1.14M | 0.14% |
27,860
| – | – |
|
50
Vanguard FTSE Developed Markets ETF
VEA
$171B
| $1.13M | 0.14% |
27,405
-7,185
| -21% | -$297K |
|